DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
Aranesp
Darbepoetin alfa
Darbepoetin alfa is a synthetic form of erythropoietin. It stimulates erythropoiesis and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Darbepoetin is marketed by Amgen under the trade name Aranesp. The drug was approved in September 2001 by the Food and Drug Administration for treatment of anemia in patients with chronic renal failure by intravenous or subcutaneous injection. In June 2001, it had been approved by the European Medicines Agency for this indication as well as the treatment of anemia in cancer patients undergoing chemotherapy...
Aranesp - List of case studies
- Myelodysplastic syndrome (MDS), with kariotype del(11)q(11)
-
supervenes, erythopoietin injections ( Procrit, Aranesp, Epogen ) may help support the red blood cells. Sometimes this is ... erythopoietin injections (Procrit, Aranesp, Epogen), G-CSF (Neupogen), lenalidomide (Revlimid), Vidaza, Dacogen, ...
- MDS – Myelodysplastic Syndrome
-
anemia supervenes, erythopoietin injections (Procrit, Aranesp, Epogen) may help support the red blood cells . Sometimes this is ... : alpha blocker, chemotherapy, erythropoietin, Procrit, Aranesp, Epogen, G-CSF, Neupogen, lenalidomide, Revlimid, Vidaza, Dacogen, ...
- Drugs
-
Antiviral prophylaxis Appendectomy Aprex Aranesp Aricept Arm A (IFN with high intensified doses) ...